October Pharma (OCPH)
Egyptian Exchange · Egypt · prices in EGP · close of 22 Oct 2026
Key indicators
| Last close | EGP 184.94 |
|---|---|
| 52-week range | 82.50 – 341.99 |
| Return, 1 month / 3 months | −23.1% / −20.1% |
| Return, 1 year / 3 years | +71.6% / +279.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 28 |
| Volatility (1 year) | 56.4% |
| Worst drawdown (1 year) | -40.3% |
| Average daily value traded | 12.00M EGP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
October Pharma (OCPH) trades on the Egyptian Exchange in Egypt. It last closed at EGP 184.94 on 22 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 166 of 276 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 71.6% and over the last three months it fell 20.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Egyptian Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 9.3% | ||
| From 52-week high | -40.3% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -20.1% | ||
| 6-month return | 24.3% | ||
| 12-month return, skipping the last month | 123.3% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.3% | ||
| Liquidity | 31 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 12.00M EGP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −6.3% |
|---|---|
| 1 month | −23.1% |
| 3 months | −20.1% |
| 6 months | +24.3% |
| 1 year | +71.6% |
| 3 years | +279.4% |
| 5 years | +576.7% |
Signals
| 50-day / 200-day average | 236.43 / 169.17 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.01 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 May 2024 | EGP 2.5000 |
| 20 Apr 2022 | EGP 4.0000 |
| 9 Jun 2021 | EGP 3.0000 |
| 27 Jul 2020 | EGP 1.5000 |
| 16 Jul 2019 | EGP 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Egyptian Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.